drugset / Trial / NCT03724292

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

NCT03724292 ↗

Phase 1 Completed 40 enrolled Vitae Pharmaceuticals, Inc.
RandomizedFactorialQuadruple-blindTreatment

Summary

This is Part 1 of a two-part, randomized, double-blind, placebo-controlled study in which VTP-43742 was administered to participants; Part 1 in healthy volunteers and Part 2 in psoriatic participants.

Timeline

Start
2015-08-01
Primary completion
2016-03-08
Completion
2016-03-08

Drugs

EvaluationDrugModalityDoseRoute
Subject VTP-43742 Small molecule — Oral

Indications